LOGO
LOGO

quick facts

  • Jinxin Technology Launches AI-Powered NAMI INSIGHT One December 31, 2025 10:15 ET

    Jinxin Technology Holding Company (NAMI), in collaboration with MLVision, Wednesday launched NAMI INSIGHT One, AI-powered smart learning glasses, which an education-specific AI model with lightweight AR technology. The launch of NAMI INSIGHT One marks the company's expansion from a pure digital-content...

  • TransDigm Group To Buy Stellant Systems For $960 Mln In Cash December 31, 2025 08:43 ET

    TransDigm Group Incorporated (TDG), an aircraft components maker, said on Wednesday that it has inked a deal to acquire Stellant Systems, Inc., a portfolio company of Arlington Capital Partners, for around $960 million in cash. Mike Lisman, CEO of TransDigm, said: "We are excited to have an agreement...

  • Jeffs' Brands's Subsidiary Plans To Purse Uplisting On Nasdaq, Stock Up In Pre-Market December 31, 2025 08:20 ET

    Jeffs' Brands Ltd (JFBR), Wednesday announced that its subsidiary Fort Technology Inc., a Global Consulting and IT Services company, is planning to pursue an uplisting on the Nasdaq Capital Market. This decision comes as Fort expects the uplisting to provide improved visibility as well as liquidity...

  • FDA Accepts Axsome's SNDA For AXS-05 In Alzheimer's Agitation With Priority Review December 31, 2025 07:15 ET

    Axsome Therapeutics Inc. (AXSM) announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (NDA) for AXS-05 (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with Alzheimer's disease. The FDA has granted the...

  • Axsome Therapeutics Advances Toward NDA Submission For AXS-12 In Narcolepsy December 31, 2025 07:04 ET

    Axsome Therapeutics, Inc. (AXSM) announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the U.S. Food and Drug Administration (FDA). The FDA feedback supports the company's planned NDA submission for AXS-12 in narcolepsy. AXS-12 (reboxetine) is a highly selective and...

  • Cable One Appoints James Holanda As CEO; Mary Meduski Elected Independent Chair December 31, 2025 06:44 ET

    Cable One Inc. (CABO) announced that James Holanda will become the company's next Chief Executive Officer and join its Board of Directors. Holanda is expected to assume his role no later than March 31, 2026, allowing him time to complete his current professional commitments. He will succeed Julia Laulis,...

  • Lincoln Gold Mining CEO Paul Saxton Steps Down; Appoints Ian Rogers As Interim December 31, 2025 01:00 ET

    Lincoln Gold Mining Inc. (LNCLF, LMG.V), a Canadian precious metals exploration and development company, on Wednesday announced that CEO and President Paul Saxton is stepping down from the role with immediate effect. The company has appointed Chair Ian Rogers as interim Chief Executive Officer. Saxton...

  • SoftBank Completes $22.5 Bln Second Closing Investment In OpenAI; Ownership Rises To 11% December 31, 2025 00:46 ET

    SoftBank Group Corp. (SFTBF, SFTBY, 9984.T), a Japanese investment holding company, on Wednesday said it has completed an additional $22.5 billion investment in OpenAI at the second closing on December 26. The company completed the first closing in April 2025 with a $7.5 billion investment through...

  • Disney To Pay $10 Mln Penalty Over Alleged Violations Of Children's Online Privacy Rules December 30, 2025 22:04 ET

    The U.S. Justice Department announced that a federal court has approved a stipulated order resolving a case against Disney Worldwide Services Inc. and Disney Entertainment Operations LLC. Under the settlement, Disney will pay $10 million in civil penalties to resolve allegations from the Federal Trade...

  • Warner Bros. Likely To Dismiss Paramount's Amended Offer : Reports December 30, 2025 21:52 ET

    Warner Bros. Discovery Inc. (WBD) is preparing to once again turn down Paramount Skydance Corp.'s unsolicited tender offer, according to reports from people familiar with the matter. The board has not yet issued a final decision but is scheduled to meet next week to evaluate the proposal. Paramount recently...

  • Ultragenyx Completes FDA BLA Submission For DTX401 Gene Therapy To Treat GSDIa December 30, 2025 21:02 ET

    Ultragenyx Pharmaceutical Inc. (RARE) announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration for DTX401 AAV gene therapy (pariglasgene brecaparvovec), intended as a treatment for Glycogen Storage Disease Type Ia (GSDIa). If...

  • Canadabis Capital Slips To Loss In Q1 December 30, 2025 20:38 ET

    Canadabis Capital Inc. (CANB.V) reported that its net loss for the first quarter was C$128,539 or break even per share compared to net income of C$321,569 or break even per share last year. Net revenues were C$3.26 million down from $5.09 million in the previous year. The company also confirmed...

  • FDA Approves Vanda's NEREUS For Motion Sickness; Shares Jump Over 20% In Overnight Trading December 30, 2025 20:11 ET

    Vanda Pharmaceuticals Inc. (VNDA) announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS (tradipitant), an oral neurokinin-1 (NK-1) receptor antagonist, for the prevention of motion-induced vomiting. This milestone marks the first new pharmacologic treatment for motion sickness...

  • Air China To Buy 60 Airbus A320NEO Series Aircraft To Increase Fleet Capacity December 30, 2025 10:17 ET

    Air China Limited (AIRYY.PK) and AIE, Tuesday announced Air China Aircraft Purchase Agreement to purchase 60 Airbus A320NEO series aircraft from Airbus company (EADSY.PK). According to the deal, the list price of the Airbus Aircraft is about $9.53 billion, which is equivalent to approximately HK$74.1...

  • AMTD IDEA Group Profit Rises In H1 2025, Stock Up In Pre-Market December 30, 2025 09:39 ET

    AMTD IDEA Group (AMTD), Tuesday announced financial results for the six months ended June 30, 2025. For the first half of fiscal year 2025, the company reported profit of $68.8 million, up 63.7 percent from last year's $42.03 million, mainly due to the additional contribution recognized from the company's...

Global Economics Weekly Update - December 22 - 26, 2025

December 26, 2025 08:42 ET
Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.